ArticleJournal of radiation research2017

Investigation of the efficacy and safety of CyberKnife hypofractionated stereotactic radiotherapy for brainstem metastases using a new evaluation criterion: 'symptomatic control'.

Masaki Nakamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.